EpiBiologics
Develops novel bispecific antibodies for targeted degradation of extracellular proteins in oncolo...
$107MSeries B
Role not disclosedActivity from announced rounds
Develops novel bispecific antibodies for targeted degradation of extracellular proteins in oncolo...
Develops medicines targeting historically undruggable protein targets in cancer
Provides AI-native due diligence for life sciences dealmaking
Pitching GV (Google Ventures)? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room